SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-154311
Filing Date
2020-05-28
Accepted
2020-05-28 16:31:20
Documents
16
Period of Report
2020-05-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d916063d8k.htm   iXBRL 8-K 39997
2 EX-4.2 d916063dex42.htm EX-4.2 213354
3 EX-5.1 d916063dex51.htm EX-5.1 17936
8 GRAPHIC g916063g0528075213286.jpg GRAPHIC 2623
  Complete submission text file 0001193125-20-154311.txt   465324

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pfe-20200528.xsd EX-101.SCH 4525
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20200528_def.xml EX-101.DEF 13709
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20200528_lab.xml EX-101.LAB 22718
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20200528_pre.xml EX-101.PRE 14677
17 EXTRACTED XBRL INSTANCE DOCUMENT d916063d8k_htm.xml XML 6259
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 20921559
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences